Calpain system dysregulation in rat brain at beta-amyloid-induced neurodegeneration

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Russian journal of bioorganic chemistry

• Publication date

  2013-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1134/S1068162013050117PMID 25702415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endocrine

  2025cited by this paper
• Lancet

  2021cited by this paper
• MEROPS: the database of proteolytic enzymes, their substrates and inhibitors

  2011cited by this paper
• Optimization of fixation methods for observation of bacterial cell morphology and surface ultrastructures by atomic force microscopy

  2011cited by this paper
• Alteration of cathepsins and actin genes expression in rat brain during ageing

  2011cited by this paper
• Proteases of the calpain family: Structure and functions

  2010cited by this paper
• Neuroprotective mechanism conferred by 17beta-estradiol on the biochemical basis of Alzheimer's disease.

  2010cited by this paper
• Calcium signaling and neurodegenerative diseases.

  2009cited by this paper
• The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

  2009cited by this paper
• Calpain-Mediated Signaling Mechanisms in Neuronal Injury and Neurodegeneration

  2008cited by this paper
• Differential Activities of the Ubiquitin–Proteasome System in Neurons versus Glia May Account for the Preferential Accumulation of Misfolded Proteins in Neurons

  2008cited by this paper
• Amyloid β peptide toxicity in differentiated PC12 cells: Calpain‐calpastatin, caspase, and membrane damage

  2008cited by this paper
• Estrogen receptor α and β differentially regulate intracellular Ca2+ dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons

  2007cited by this paper
• Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.

  2007cited by this paper
• Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.

  2007cited by this paper
• Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide

  2007cited by this paper
• Calpain-calcineurin signaling in the pathogenesis of calcium-dependent disorder.

  2007cited by this paper
• Changes in calcium dynamics following the reversal of the sodium-calcium exchanger have a key role in AMPA receptor-mediated neurodegeneration via calpain activation in hippocampal neurons

  2007cited by this paper
• Cell signaling and neuronal death.

  2007cited by this paper
• Mechanisms of neuroprotection by estrogen

  2006cited by this paper
• Early activation and redistribution of calpain activity in skeletal muscle during hindlimb unweighting and reweighting.

  2006cited by this paper
• Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia.

  2006cited by this paper
• Oestrogen receptor subtype‐specific repression of calpain expression and calpain enzymatic activity in neuronal cells – implications for neuroprotection against Ca2+‐mediated excitotoxicity

  2006cited by this paper
• Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis

  2006cited by this paper
• IL-13受体α2降低血吸虫病肉芽肿的炎症反应并延长宿主存活时间[英]/Mentink-Kane MM,Cheever AW，Thompson RW，et al//Proc Natl Acad Sci U S A

  2005cited by this paper
• Activity of calpain in subcellular fractions of the rat brain

  2004cited by this paper
• Differential Compartmentalization of the Calpain/Calpastatin Network with the Endoplasmic Reticulum and Golgi Apparatus*

  2004cited by this paper
• The calpain system.

  2003cited by this paper
• Alzheimer's disease: the pharmacological pathway

  2003cited by this paper
• Calcium dyshomeostasis and intracellular signalling in alzheimer's disease

  2002cited by this paper
• Neuroprotection by estradiol.

  2001cited by this paper
• A “Protease Activation Cascade” in the Pathogenesis of Alzheimer's Disease

  2000cited by this paper
• Calpain zymography with casein or fluorescein isothiocyanate casein.

  2000cited by this paper
• Neurotoxicity induces cleavage of p35 to p25 by calpain

  2000cited by this paper
• Neuronal cell death: a demise with different shapes.

  1999cited by this paper
• Aggresomes: A Cellular Response to Misfolded Proteins

  1998cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Conformational disease.

  1997cited by this paper
• The Calpain Hypothesis of Neurodegeneration: Evidence for a Common Cytotoxic Pathway

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Changes in Brain Protease Activity in Aging

  1996cited by this paper
• Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a

  1994cited by this paper
• Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration.

  1993cited by this paper
• Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons

  1993cited by this paper
• Localization of the Ca(2+)-dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle.

  1992cited by this paper
• Localization of the Ca2+‐dependent proteinases and their inhibitor in normal, fasted, and denervated rat skeletal muscle

  1992cited by this paper
• Molecular biology of prion diseases

  1991cited by this paper
• Proteolytic processing of beta-amyloid precursor by calpain I

  1990cited by this paper
• Proteolysis of the protein inhibitor of calcium-dependent proteases produces lower molecular weight fragments that retain inhibitory activity.

  1988cited by this paper
• Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function

  1987cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Spatial Localization Does Not Require the Presence of Local Cues

  1981cited by this paper
• Canine cardiac calcium‐dependent proteases: Resolution of two forms with different requirements for calcium

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• [Modulation of Ca(2+)-Dependent Proteiolysis under the Action of Weak Low-Frequency Magnetic Fields].

  2015cites this paper
• Neuroprotective strategies against calpain-mediated neurodegeneration

  2015cites this paper
• Modulation of Ca2+-dependent proteolysis under the action of weak low-frequency magnetic fields

  2015cites this paper
• Neuroprotective strategies against calpain-mediated neurodegeneration

  2015cites this paper
• [Calpains and their endo- and exogenous regulators in various neurodegeneration models].

  2014cites this paper
• Biochemical markers of pollutant responses in macrozoobenthos from the White Sea: intracellular proteolysis.

  2014cites this paper
• Calpains and their endo- and exogenous regulators in various models of neurodegeneration

  2014cites this paper